Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028

List of Tables

Abstract

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028

The human immunodeficiency virus (HIV) rapid test kits market is forecasted to grow by USD 294.96 mn during 2023-2028, accelerating at a CAGR of 6.52% during the forecast period. The report on the human immunodeficiency virus (HIV) rapid test kits market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.45%
CAGR	6.52%
Incremental Value	$294.96mn

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a rise in awareness programs for HIV testing, growing demand for point-of-care testing for HIV, and a high prevalence of HIV.

Technavio's human immunodeficiency virus (HIV) rapid test kits market is segmented as below:

By End-user

Diagnostic centers
Hospitals
clinics

By Type

HIV rapid immunoassay test
HIV rapid molecular diagnostic test

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the efforts to increase pre-marital screenings for HIV as one of the prime reasons driving the human immunodeficiency virus (HIV) rapid test kits market growth during the next few years. Also, increasing clinical studies by researchers and promotional activities by manufacturers, and the availability of a broad range of HIV rapid test kits by vendors will lead to sizable demand in the market.

The report on the human immunodeficiency virus (HIV) rapid test kits market covers the following areas:

Human immunodeficiency virus (HIV) rapid test kits market sizing
Human immunodeficiency virus (HIV) rapid test kits market forecast
Human immunodeficiency virus (HIV) rapid test kits market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human immunodeficiency virus (HIV) rapid test kits market vendors that include Abbott Laboratories, AccuQuik Test Kits, Amkay Products Pvt. Ltd., Becton Dickinson and Co., Bhat Bio Tech India Pvt Ltd., bioLytical Laboratories Inc., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Healgen Scientific, LLC, Hologic Inc., J. Mitra and Co. Pvt. Ltd., MP Biomedicals Inc., Oragenics Inc., OraSure Technologies Inc., Pathkits Heathcare Pvt. Ltd., and SHINE SA. Also, the human immunodeficiency virus (HIV) rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR45322

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global human immunodeficiency virus (HIV) rapid test kits market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global human immunodeficiency virus (hiv) rapid test kits market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Diagnostic centers - Market size and forecast 2023-2028
Exhibit 34: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
6.4 Hospitals and clinics - Market size and forecast 2023-2028
Exhibit 38: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Exhibit 42: Market opportunity by End-user ($ million)
Exhibit 43: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 44: Chart on Type - Market share 2023-2028 (%)
Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 HIV rapid immunoassay test - Market size and forecast 2023-2028
Exhibit 48: Chart on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
7.4 HIV rapid molecular diagnostic test - Market size and forecast 2023-2028
Exhibit 52: Chart on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 56: Market opportunity by Type ($ million)
Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share by geography 2023-2028 (%)
Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 99: Market opportunity by geography ($ million)
Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 AccuQuik Test Kits
Exhibit 112: AccuQuik Test Kits - Overview
Exhibit 113: AccuQuik Test Kits - Product / Service
Exhibit 114: AccuQuik Test Kits - Key offerings
12.5 Becton Dickinson and Co.
Exhibit 115: Becton Dickinson and Co. - Overview
Exhibit 116: Becton Dickinson and Co. - Business segments
Exhibit 117: Becton Dickinson and Co. - Key news
Exhibit 118: Becton Dickinson and Co. - Key offerings
Exhibit 119: Becton Dickinson and Co. - Segment focus
12.6 bioLytical Laboratories Inc.
Exhibit 120: bioLytical Laboratories Inc. - Overview
Exhibit 121: bioLytical Laboratories Inc. - Product / Service
Exhibit 122: bioLytical Laboratories Inc. - Key offerings
12.7 bioMerieux SA
Exhibit 123: bioMerieux SA - Overview
Exhibit 124: bioMerieux SA - Product / Service
Exhibit 125: bioMerieux SA - Key news
Exhibit 126: bioMerieux SA - Key offerings
12.8 Chembio Diagnostics Inc.
Exhibit 127: Chembio Diagnostics Inc. - Overview
Exhibit 128: Chembio Diagnostics Inc. - Product / Service
Exhibit 129: Chembio Diagnostics Inc. - Key offerings
12.9 Danaher Corp.
Exhibit 130: Danaher Corp. - Overview
Exhibit 131: Danaher Corp. - Business segments
Exhibit 132: Danaher Corp. - Key news
Exhibit 133: Danaher Corp. - Key offerings
Exhibit 134: Danaher Corp. - Segment focus
12.10 DrSafeHands
Exhibit 135: DrSafeHands - Overview
Exhibit 136: DrSafeHands - Product / Service
Exhibit 137: DrSafeHands - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Fujirebio Holdings Inc.
Exhibit 143: Fujirebio Holdings Inc. - Overview
Exhibit 144: Fujirebio Holdings Inc. - Product / Service
Exhibit 145: Fujirebio Holdings Inc. - Key offerings
12.13 Healgen Scientific, LLC
Exhibit 146: Healgen Scientific, LLC - Overview
Exhibit 147: Healgen Scientific, LLC - Product / Service
Exhibit 148: Healgen Scientific, LLC - Key offerings
12.14 Hologic Inc.
Exhibit 149: Hologic Inc. - Overview
Exhibit 150: Hologic Inc. - Business segments
Exhibit 151: Hologic Inc. - Key news
Exhibit 152: Hologic Inc. - Key offerings
Exhibit 153: Hologic Inc. - Segment focus
12.15 J. Mitra and Co. Pvt. Ltd.
Exhibit 154: J. Mitra and Co. Pvt. Ltd. - Overview
Exhibit 155: J. Mitra and Co. Pvt. Ltd. - Product / Service
Exhibit 156: J. Mitra and Co. Pvt. Ltd. - Key offerings
12.16 MP Biomedicals Inc.
Exhibit 157: MP Biomedicals Inc. - Overview
Exhibit 158: MP Biomedicals Inc. - Key offerings
12.17 OraSure Technologies Inc.
Exhibit 159: OraSure Technologies Inc. - Overview
Exhibit 160: OraSure Technologies Inc. - Business segments
Exhibit 161: OraSure Technologies Inc. - Key offerings
Exhibit 162: OraSure Technologies Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 163: Inclusions checklist
Exhibit 164: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 165: Currency conversion rates for US$
13.4 Research methodology
Exhibit 166: Research methodology
Exhibit 167: Validation techniques employed for market sizing
Exhibit 168: Information sources
13.5 List of abbreviations
Exhibit 169: List of abbreviations